You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 5, April 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Gram-Negative Bacteremias

Analysis of Factors for Clinical Assessment of Gentamicin Resistance

Joseph M. Lynch, MD; Glenn R. Hodges, MD; Gary M. Clark, PhD; David L. Dworzack, MD

Arch Intern Med. 1981;141(5):582-586.


Abstract

• We reviewed the charts of 163 patients with 183 episodes of Gram-negative bacillary bacteremia to determine a clinical profile that would select patients at high risk for experiencing gentamicin-sulfate-resistant Gram-negative bacillary bacteremia at our hospital. Gentamicin-resistant Gram-negative bacilli were only associated with institution-acquired bacteremia. Among institution-acquired episodes, urinary tract infection, diagnostic or therapeutic procedures of the lower respiratory tract or urinary tract, presence of pneumonic infiltrate on chest roentgenogram, prior therapy with gentamicin, and prior therapy with other antibiotics were significant risk factors. Because only two of the 29 gentamicin-resistant bacteria that were tested against amikacin base were resistant to amikacin, we advocate initial treatment with amikacin for patients with evidence of an institution-acquired Gram-negative bacteremic episode. Gentamicin is still our initial choice for a community-acquired episode.

(Arch Intern Med 1981;141:582-586)



Author Affiliations

From the Medical Service, Veterans Administration Medical Center, Kansas City, Mo (Dr Hodges); and the Division of Infectious Diseases, Departments of Medicine (Drs Lynch, Hodges, and Dworzack) and Biometry (Dr Clark), University of Kansas College of Health Sciences, Kansas City.


Footnotes

Accepted for publication April 30, 1980.

Reprint requests to Medical Service (111), Veterans Administration Medical Center, 4801 Linwood Blvd, Kansas City, MO 64128 (Dr Hodges).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Gentamicin Resistance Among Gram-negative Bacillary Blood Isolates in a Hospital With Long-term Use of Gentamicin
Mylotte
Arch Intern Med 1987;147:1642-1644.
ABSTRACT  

Enterobacter Bacteremia: An Analysis of 50 Episodes
Bouza et al.
Arch Intern Med 1985;145:1024-1027.
ABSTRACT  

Progressive Increase in Antibiotic Resistance of Gram-negative Bacterial Isolates: Walter Reed Hospital, 1976 to 1980: Specific Analysis of Gentamicin, Tobramycin, and Amikacin Resistance
Cross et al.
Arch Intern Med 1983;143:2075-2080.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.